MedinCell And Two More Euronext Paris Growth Stocks With High Insider Ownership

In This Article:

As the French market navigates through a period of political uncertainty with upcoming elections, investors are closely monitoring shifts in economic indicators and market sentiments. In such times, growth stocks with high insider ownership can offer a unique appeal, as these insiders may have a deeper commitment to the company's long-term success.

Top 10 Growth Companies With High Insider Ownership In France

Name

Insider Ownership

Earnings Growth

VusionGroup (ENXTPA:VU)

13.5%

25.2%

Groupe OKwind Société anonyme (ENXTPA:ALOKW)

24.8%

30.8%

Adocia (ENXTPA:ADOC)

12.1%

59.8%

Icape Holding (ENXTPA:ALICA)

30.2%

26.1%

Arcure (ENXTPA:ALCUR)

21.4%

42.4%

La Française de l'Energie (ENXTPA:FDE)

20.1%

31.9%

S.M.A.I.O (ENXTPA:ALSMA)

17.3%

35.2%

Munic (ENXTPA:ALMUN)

29.4%

150%

WALLIX GROUP (ENXTPA:ALLIX)

19.8%

101.6%

MedinCell (ENXTPA:MEDCL)

16.4%

74.9%

Click here to see the full list of 22 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

MedinCell

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A. is a French pharmaceutical company specializing in the development of long-acting injectable medications across multiple therapeutic areas, with a market capitalization of approximately €410.34 million.

Operations: The company generates revenue primarily from its pharmaceutical segment, totaling €11.95 million.

Insider Ownership: 16.4%

Earnings Growth Forecast: 74.9% p.a.

MedinCell, a French pharmaceutical company, reported a decrease in sales and revenue for the fiscal year ending March 2024 but reduced its net loss from the previous year. Recent clinical trials have shown mixed results, with its F14 drug not meeting primary endpoints but showing improvements in secondary measures. Despite high volatility in its share price, MedinCell is anticipated to grow revenues at 43.7% annually and become profitable within three years, driven by promising developments like the TEV-‘749 schizophrenia treatment and collaborations with major industry players like AbbVie.

ENXTPA:MEDCL Ownership Breakdown as at Jul 2024
ENXTPA:MEDCL Ownership Breakdown as at Jul 2024

OVH Groupe

Simply Wall St Growth Rating: ★★★★☆☆

Overview: OVH Groupe S.A. is a global provider of public and private cloud services, shared hosting, and dedicated server solutions, with a market capitalization of approximately €1.13 billion.

Operations: The company generates revenue through three primary segments: public cloud (€169.01 million), private cloud (€589.61 million), and web cloud (€185.43 million).